The FLUOX-PMS trial: Underestimating the challenge in progressive multiple sclerosis trials
Mult Scler
.
2019 Nov;25(13):1697-1699.
doi: 10.1177/1352458519856985.
Epub 2019 Jun 20.
Authors
Jeremy Chataway
1
,
Christopher J Weir
2
,
Robert J Fox
3
Affiliations
1
Queen Square Multiple Sclerosis Centre, UCL Queen Square Institute of Neurology, London, UK.
2
Edinburgh Clinical Trials Unit, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.
3
Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH, USA.
PMID:
31218918
DOI:
10.1177/1352458519856985
No abstract available
Publication types
Comment
MeSH terms
Humans
Multiple Sclerosis*
Multiple Sclerosis, Chronic Progressive*